Fructose Intolerance
6
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Observational Study on the Safety and Efficacy of the Medical Product Fructosin.
Investigation of Alanine in Fructose Intolerance: A Dose Ranging Study
Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders
Investigation of Supplemental L-alanine in the Management of Dietary Fructose Intolerance
Clinical Utility of Breath Tests in GI
Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance?